Alain Schaffter
Director of Finance/CFO bij BACHEM HOLDING AG
Vermogen: 62 352 $ op 31-03-2024
Profiel
De heer Alain Schaffter is financieel directeur bij Bachem Holding AG en financieel directeur bij Solvias AG.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-12-2022 | 650 ( 0.00% ) | 62 352 $ | 31-03-2024 |
Actieve functies van Alain Schaffter
Bedrijven | Functie | Begin |
---|---|---|
BACHEM HOLDING AG | Director of Finance/CFO | 01-02-2021 |
Eerdere bekende functies van Alain Schaffter
Bedrijven | Functie | Einde |
---|---|---|
SPEXIS AG | Director of Finance/CFO | - |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland. | Comptroller/Controller/Auditor | - |
ACINO HOLDING AG | Director of Finance/CFO | - |
Solvias AG
Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Director of Finance/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BACHEM HOLDING AG | Health Technology |
SPEXIS AG | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
PricewaterhouseCoopers AG (Zurich)
PricewaterhouseCoopers AG (Zurich) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland. | Commercial Services |
Solvias AG
Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |